Tuberculosis treatment by restoring sensitivity to key drugs with Mycobacterial Tolerance Inhibitor
Diarienummer | |
Koordinator | QURETECH BIO AB - QURETECH BIO AB c/o Akiri AB |
Bidrag från Vinnova | 4 000 kronor |
Projektets löptid | september 2016 - september 2016 |
Status | Avslutat |